Financials data is unavailable for this security.
View more
Year on year Editas Medicine Inc grew revenues 296.32% from 19.71m to 78.12m while net income improved from a loss of 220.43m to a smaller loss of 153.22m.
Gross margin | -- |
---|---|
Net profit margin | -340.96% |
Operating margin | -370.03% |
Return on assets | -50.61% |
---|---|
Return on equity | -78.56% |
Return on investment | -60.06% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Editas Medicine Inc fell by 17.87m. Cash Flow from Financing totalled 118.04m or 151.09% of revenues. In addition the company used 132.18m for operations while cash used for investing totalled 3.73m.
Cash flow per share | -2.49 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.13 |
---|---|
Tangible book value per share | 2.13 |
More ▼
Balance sheet in USDView more
Current ratio | 3.75 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼